Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Simplified Diagnosis Tool for Chinese IBS-C (Irritable Bowel Syndrome With Constipation) Patients

NCT04968652 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04968652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04968652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Simplified Diagnosis Tool for Chinese IBS-C (Irritable Bowel Syndrome With Constipation) Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 1, 2021
Completion date
October 28, 2022
Enrollment
300 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

functional constipation, irritable bowel syndrome with constipation